Back to Search Start Over

Double-blind comparison of prenylamine and penbutolol in patients with angina pectoris.

Authors :
Slegers LC
Vermeulen A
Sumajow CA
Source :
The Journal of international medical research [J Int Med Res] 1985; Vol. 13 (4), pp. 229-35.
Publication Year :
1985

Abstract

This study was performed to re-evaluate the clinical position of prenylamine in the management of angina pectoris. After 1 week withdrawal of all anti-anginal agents, followed by another week of placebo administration, seventeen patients were allocated at random to 6 weeks treatment with either penbutolol 40 mg once a day or prenylamine 60 mg t.i.d. Clinical examination, exercise test and anginal attack rate were recorded every 2 weeks. Both drugs reduced the anginal attack rate. None of the drugs caused a significant increase in maximal workload or a significant change in ST-segment depression. Beside a substantially lower rate-pressure product at maximal comparable workload in the penbutolol group (p less than 0.001), no significant differences were observed between the two drugs. No adverse reactions were reported. From these results one can conclude that prenylamine and penbutolol do not differ in their anti-anginal effect. Therefore we are of the opinion that prenylamine has a place in the therapeutic armamentarium for the management of angina pectoris, particularly in patients where beta-blocking agents are contraindicated or in patients who have experienced side-effects of beta-blocking or calcium-entry blocking agents.

Details

Language :
English
ISSN :
0300-0605
Volume :
13
Issue :
4
Database :
MEDLINE
Journal :
The Journal of international medical research
Publication Type :
Academic Journal
Accession number :
3899772
Full Text :
https://doi.org/10.1177/030006058501300406